Sanofi claims high-rises neighboring its Toronto facility would pose 'national security' threat
Sanofi isn’t so happy with one of its neighbors. The French pharma giant is going to battle against a Canadian developer’s proposal to build two, 30-plus-story residential towers less than half a mile away from its Toronto facility, citing “national security concerns.”
The news comes just under a year after Sanofi announced it’s dumping more than $676 million into a new vaccine manufacturing facility at the Toronto site, which will be responsible for additional antigen and filling capacity for its Fluzone high-dose quadrivalent vaccine. The new facility should be up and running in 2026, the company said back in March.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,600+ biopharma pros reading Endpoints daily — and it's free.